✦ LIBER ✦

Synthesis and Structure−Activity Relationship of Aminobenzophenones. A Novel Class of p38 MAP Kinase Inhibitors with High Antiinflammatory Activity

✍ Scribed by Ottosen, Erik Rytter; Sørensen, Morten Dahl; Björkling, Fredrik; Skak-Nielsen, Tine; Fjording, Marianne Scheel; Aaes, Helle; Binderup, Lise

Book ID: 126289440
Publisher: American Chemical Society
Year: 2003
Tongue: English
Weight: 245 KB
Volume: 46
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm030851s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis, Crystal Structure, and Activi

Synthesis, Crystal Structure, and Activity of Pyrazole-Based Inhibitors of p38 Kinase

✍ Graneto, Matthew J.; Kurumbail, Ravi G.; Vazquez, Michael L.; Shieh, Huey-Sheng; 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 645 KB

5-Cyanopyrimidine Derivatives as a Novel

5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP Kinase

✍ Liu, Chunjian; Wrobleski, Stephen T.; Lin, James; Ahmed, Gulzar; Metzger, Axel; 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 297 KB

Synthesis and biological activity of pyr

Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1

✍ Robert M. Tynebor; Meng-Hsin Chen; Swaminathan R. Natarajan; Edward A. O’Neill; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 705 KB

The development and synthesis of potent p38α MAP kinase inhibitors containing a pyridazinone platform is described. Evolution of the p38α selective pyridopyridazin-6-one series from the p38α/β dual inhibitor 2H-quinolizin-2-one series will be discussed in full detail.

Synthesis and biological activity of pyr

Synthesis and biological activity of pyridopyridazin-6-one p38α MAP kinase inhibitors. Part 2

✍ Tynebor, Robert M.; Chen, Meng-Hsin; Natarajan, Swaminathan R.; O’Neill, Edward 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Pharmacological profile of AW-814141, a

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

✍ Puneet Chopra; Onkar Kulkarni; Shashank Gupta; Malini Bajpai; Vijay Kanoje; Mani 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Design and Structure−Activity Relationsh

Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors

✍ Hennequin, Laurent F.; Thomas, Andrew P.; Johnstone, Craig; Stokes, Elaine S. E. 📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 547 KB